Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heliox Therapy Assessment in COPD Exacerbation
2008-005660-13Phase 4Completed
- Sponsor
- BOC Ltd.
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of heliox21 in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by BOC Ltd. Primary endpoint: Feasibility of study procedures and protocol. Started Oct 2008; status: completed.
02
Drugs
heliox21
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-005660-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005660-13.